National Institute on Minority Health and Health Disparities; Notice of Closed Meetings, 1814-1815 [2020-00273]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
1814
Federal Register / Vol. 85, No. 8 / Monday, January 13, 2020 / Notices
be found on the OMH website under the
heading About OMH.
DATES: The meeting will be held on
Thursday, January 30, 2020, 9:00 a.m. to
5:00 p.m. ET, and Friday, January 31,
2020, 9:00 a.m. to 3:00 p.m. ET. Day 2
may end earlier than 3:00 p.m. ET if
ACMH completes it work before 3:00
p.m. ET.
ADDRESSES: The meeting will be
accessible by attendance in-person or by
webcast on the internet. In-person and
webcast participants must register prior
to the meeting. The meeting will be held
at the 5600 Fishers Lane Building, Room
05E49, 5600 Fishers Lane, Rockville,
Maryland 20187. Registered webcast
participants will receive the webcast
information prior to the meeting.
FOR FURTHER INFORMATION CONTACT:
Violet Woo, Designated Federal Officer,
Advisory Committee on Minority
Health, Office of Minority Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Plaza Level, Rockville,
Maryland 20852. Phone: 240–453–2882;
fax: 240–453–2883; email OMH–
ACMH@hhs.gov.
SUPPLEMENTARY INFORMATION: In
accordance with Public Law 105–392,
the ACMH was established to provide
advice to the Deputy Assistant Secretary
for Minority Health on improving the
health of each racial and ethnic
minority group and on the development
of goals and specific program activities
of the OMH.
The topics to be discussed during this
meeting will include strategies to
improve access to and success of
clinical prevention services among
racial and ethnic minority populations.
The recommendations will be given to
the Deputy Assistant Secretary for
Minority Health to inform efforts related
to the Department’s community-wide,
chronic disease prevention strategies.
The meeting is open to the public.
Any individual who wishes to attend
the meeting in person or by webcast
must register by sending an email to
OMH–ACMH@hhs.gov by January 24,
2020. Each registrant should provide
their name, affiliation, phone number,
email address, days attending, and if
participation is in-person or via
webcast. After registration, individuals
participating by webcast will receive
webcast access information via email.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact BLH Technologies, Inc. at (240)
399–8735 and reference this meeting.
Requests for special accommodations
VerDate Sep<11>2014
16:32 Jan 10, 2020
Jkt 250001
should be made at least ten (10)
business days prior to the meeting.
Members of the public will have an
opportunity to provide comments at the
meeting. Public comments will be
limited to two minutes per speaker
during the time allotted. Individuals
who would like to submit written
statements should email OMH–ACMH@
hhs.gov or mail their comments to the
Designated Federal Officer contact cited
above so it is received by the Designated
Federal Officer at least five (5) business
days prior to the meeting.
Any members of the public who wish
to distribute electronic or printed
material(s) related to this meeting’s
topic to ACMH members should email
OMH–ACMH@hhs.gov or mail their
material to the Designated Federal
Officer contact cited above. The material
should be received by the Designated
Federal Officer at least five (5) business
days prior to the meeting.
Dated: December 30, 2019.
Violet Woo,
Designated Federal Officer, Advisory
Committee on Minority Health.
[FR Doc. 2020–00307 Filed 1–10–20; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PAR–16–412: NIAID
Resource-Related Research Projects (R24).
Date: February 4, 2020.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Room 3E71, Rockville, MD
20892 (Telephone Conference Call).
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
Contact Person: Ann Marie M. Brighenti,
Ph.D., Scientific Review Officer, Program
Management & Operations Branch, Division
of Extramural Activities, Scientific Review
Program, Room 3E71, National Institutes of
Health, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane
Rockville, MD 20852, 301–761–3100,
AnnMarie.Cruz@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 7, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00270 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; ZMD1 DRI M1
Special Emphasis Panel for Review of
Mentored Research Scientist Development
Award (K01).
Date: February 12–13, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Ave.,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(301) 402–1366, ismonddr@mail.nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; NIMHD Research
Career Development Awards (Ks).
E:\FR\FM\13JAN1.SGM
13JAN1
Federal Register / Vol. 85, No. 8 / Monday, January 13, 2020 / Notices
Date: March 4, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(301) 594–7784, Xinli.Nan@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Specialized Centers
of Excellence on Environmental Health
Disparities Research (P50 Clinical Trial
Optional).
Date: March 10–12, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Gaithersburg, Walker
Conference Room and Whetstone Conference
Room 2, Montgomery Village Avenue,
Gaithersburg, MD 20879.
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, Division of
Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201
Wisconsin Avenue, Ste. 525, MSC. 9206,
Bethesda, MD 20892, (301) 451–9536,
mlaudesharp@mail.nih.gov.
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00273 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NTU.
Date: February 5, 2020.
VerDate Sep<11>2014
16:32 Jan 10, 2020
Jkt 250001
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, DEM1,
6701 Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Barbara J. Nelson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4874, 301–435–0806, nelsonbj@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: January 7, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00268 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Drug
Repositioning and Combination Therapy for
AD.
Date: February 11, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
1815
Name of Committee: National Institute on
Aging Special Emphasis Panel; Pepper Center
Review.
Date: February 19–20, 2020.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda,
Conference Room, Bethesda Chevy Chase,
7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (301) 827–
7428, anita.undale@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development.
Date: February 19, 2020.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00269 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 85, Number 8 (Monday, January 13, 2020)]
[Notices]
[Pages 1814-1815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel; ZMD1 DRI M1 Special
Emphasis Panel for Review of Mentored Research Scientist Development
Award (K01).
Date: February 12-13, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Gateway Plaza, 7201
Wisconsin Ave., Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Deborah Ismond, Ph.D., Scientific Review
Officer, Division of Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD
20892, (301) 402-1366, [email protected].
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel; NIMHD Research Career
Development Awards (Ks).
[[Page 1815]]
Date: March 4, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xinli Nan, M.D., Ph.D., Scientific Review
Officer, Division of Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD
20892, (301) 594-7784, [email protected].
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel; Specialized Centers of
Excellence on Environmental Health Disparities Research (P50
Clinical Trial Optional).
Date: March 10-12, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Gaithersburg, Walker Conference Room and
Whetstone Conference Room 2, Montgomery Village Avenue,
Gaithersburg, MD 20879.
Contact Person: Maryline Laude-Sharp, Ph.D., Scientific Review
Officer, Division of Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201 Wisconsin Avenue, Ste. 525,
MSC. 9206, Bethesda, MD 20892, (301) 451-9536,
[email protected].
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-00273 Filed 1-10-20; 8:45 am]
BILLING CODE 4140-01-P
